CEOS

Psykey is an OTC-traded health and wellness company operating under the ticker CEOS and focused on mycology-based entheogenic, adaptogenic, and nootropic products. The company markets functional mushroom-infused consumer products such as coffee, tea, supplements, and drink mixes, while also describing longer-term efforts in psychedelic and entheogen-based therapeutic development. Psykey has historically operated under the name CeCors, and public disclosures indicate that the legal issuer name reverted to CeCors, Inc. in 2023 even though financial portals still commonly associate the CEOS ticker with Psykey. Its business appears to span both commercial wellness products and early-stage therapeutic R&D related to composition, bioavailability, and targeted delivery of mushroom- or entheogen-derived formulations. Available public information does not indicate an advanced clinical pipeline.